Welcome to our dedicated page for Walgreen Boots news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreen Boots stock.
This page provides a focused view of news and announcements historically associated with Walgreens Boots Alliance, Inc. (formerly Nasdaq: WBA) and its related businesses, including Walgreens and Walgreens Specialty Pharmacy. Company communications highlight Walgreens as a U.S. retail pharmacy brand founded in 1901 that serves nearly 9 million customers and patients each day across approximately 8,500 stores in the U.S. and Puerto Rico, and Walgreens Boots Alliance as a pharmacy-led health and wellbeing enterprise formed through the combination of Walgreens and Alliance Boots.
News related to WBA and Walgreens has covered several key themes. One major area is corporate transactions and capital markets activity. In 2025, a series of announcements detailed the Agreement and Plan of Merger under which Blazing Star Merger Sub, Inc. merged with and into Walgreens Boots Alliance, Inc., resulting in the company becoming a wholly owned subsidiary of Blazing Star Parent, LLC, an affiliate of Sycamore Partners. Related releases described tender offers and consent solicitations for various series of Walgreens Boots Alliance and Walgreen Co. notes, pricing terms, extensions of expiration times and settlement dates, and the final results of these offers.
Another important news category involves the company’s transition from public to private ownership. A Form 8-K filed on August 28, 2025 describes the completion of the merger, the cash consideration and divested asset proceed rights received by shareholders, and the cessation of trading of WBA common stock and certain notes on Nasdaq. A subsequent Form 25 documents the removal of these securities from listing, and a Form 15 filed on September 8, 2025 terminates registration and suspends reporting obligations. Sycamore Partners separately announced the completion of its acquisition of Walgreens Boots Alliance, Inc. and its intention that Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD operate as standalone companies under private ownership.
Operational and healthcare-focused news also features prominently. Walgreens Specialty Pharmacy announced an expansion of its limited distribution drug network to 265 products, emphasizing its role in specialty medications for patients with rare, complex and chronic diseases and its independence from pharmacy benefit managers. Walgreens has also issued releases on vaccination services, including nationwide flu shot availability for individuals three years and older, walk-in and scheduled appointments, digital check-in features and incentives for myWalgreens members receiving vaccines.
Investors and observers using this news page can review historical coverage of WBA’s merger process, debt tender offers, governance and shareholder actions, as well as Walgreens’ specialty pharmacy initiatives and vaccination programs. For those tracking the evolution of the company, these articles collectively document WBA’s path from a publicly traded integrated healthcare and retail group to a privately held organization under Sycamore Partners, while also illustrating how Walgreens positions its pharmacies and specialty operations within the broader healthcare landscape.
Walgreens has announced a new wave of price reductions, extending their commitment to help customers save on over 1,300 products across various categories. This initiative follows similar efforts started in October 2023. Key price drops include Eucerin Advance Repair Hand Cream (now $5.99, down from $7.29) and Nice! Mini Pretzels (now $1.99, down from $2.79).
Additionally, Walgreens will reintroduce its myW Days promotional campaign in mid-July, offering personalized deals to its 110 million loyalty program members. These measures are designed to alleviate financial pressures on consumers and improve access to essential items.
Walgreens is launching its inaugural community health fair, “Walgreens en tu Comunidad,” in San Juan, Puerto Rico on June 8. The event aims to enhance access to health services and education, featuring health screenings, vaccinations, and various health-related activities. Key offerings include free HIV testing, blood pressure screenings, and routine immunizations. The fair will also provide CPR demonstrations and health education from the American Heart Association, prenatal vitamins from Vitamin Angels, and consultations from Walgreens beauty and wellness experts. Special guests include Puerto Rico senator Nitza Moran Trinidad and Walgreens' chief customer officer, Tracey Brown. The event will be held from 10 a.m. to 4 p.m. ET at the Walgreens store in Montehiedra.
Walgreens celebrated Clinical Trials Day with an event in Boston highlighting women's health in clinical trials and healthcare innovation. Kendal Whitlock, head of digital optimization for Walgreens Clinical Trials, emphasized raising awareness about gender-specific health disparities and the importance of women's participation in medical research. Keynote speakers, including Walgreens Chief Clinical Trials Officer Ramita Tandon and Dr. Yvette Cozier, shared insights on increasing women's involvement in clinical trials. Walgreens announced a new clinical trials center in Malden and highlighted milestones, such as reaching over 4 million potential trial participants with over 60% being women.
Walgreens Boots Alliance (WBA) has sold approximately $400 million worth of Cencora (COR) shares through a stock repurchase agreement, decreasing its ownership from 13% to 12%.
The proceeds will be used mainly for debt reduction and general corporate purposes, supporting WBA's strategy to enhance its health services rooted in retail pharmacy.
The sale does not affect the ongoing collaboration or long-term strategic partnership between the companies. Ornella Barra, COO International of WBA, will continue to serve on Cencora's Board of Directors.
Walgreens has announced the launch of its over-the-counter Walgreens Brand Naloxone HCl Nasal Spray, effective in reversing opioid overdoses.
Retailing at $34.99, it is a more affordable option compared to the national brand. Initially available online, it will be in all stores by the end of the month. This initiative aims to improve access to naloxone, potentially lowering the impact of the opioid epidemic in the U.S.
Dr. Priya Mammen, Senior Medical Director at Walgreens, emphasized the importance of this move in combating opioid overdoses. The product has received approval from the U.S. Food and Drug Administration.
Walgreens is honoring veterans, active-duty military personnel, and their families with a Memorial Day weekend discount from May 24 to May 27. Eligible customers with a myWalgreens® membership and valid military ID or proof of service will receive a 20% discount on regularly priced products at any Walgreens or Duane Reade stores nationwide. Exclusions apply, including alcohol, dairy, tobacco, and prescription items. The myWalgreens® membership is free and available at checkout. This initiative underscores Walgreens' commitment to supporting the military community.
Walgreens partners with Dion's Chicago Dream to address food insecurity in the Chicagoland area by providing fresh produce to over 275 households and 1,000 residents weekly for a year. The collaboration aims to improve health outcomes, create jobs, and promote health equity.
Walgreens is enhancing its specialty pharmacy services by introducing Walgreens Specialty Pharmacy, which includes Gene and Cell Services Pharmacy and Innovation Center. The company aims to improve patient outcomes, provide value to payers, and leverage its neighborhood pharmacies into growing healthcare areas. Walgreens Specialty Pharmacy offers a wide range of services, including gene and cell therapy, central specialty pharmacies, community-based specialty pharmacies, specialty-trained pharmacists, patient advocacy support, and distribution drugs. The company is focused on breaking through healthcare silos and providing comprehensive care to help payers manage specialty costs. With $24 billion in annual enterprise specialty revenue, Walgreens Specialty Pharmacy is the largest independent provider in the U.S. The company is committed to an integrated care model to serve patients effectively.
DoorDash and Walgreens have teamed up to offer SNAP customers the ability to make purchases at Walgreens using their SNAP/EBT cards. DoorDash is the first platform to enable SNAP customers to buy directly from Walgreens, expanding food access for millions of individuals living in food deserts or SNAP/EBT communities. This partnership provides convenient access to over 4,000 SNAP-eligible products for delivery within an hour through DoorDash, helping consumers fulfill their grocery needs quickly and affordably.
For National Women's Health Month, Walgreens Healthcare Supervisor La Vonia Cannon, shares her inspiring 24-year career journey at Walgreens. Starting as a pharmacist, she now oversees 62 stores, supports district managers, and leads the Women of WBA business resource group. She emphasizes women's leadership, wellness, and empowerment, organizing events focused on health and work-life balance. Her dedication to professional growth, health advocacy, and work-life balance exemplifies her leadership and commitment to women's health.
FAQ
What is the current stock price of Walgreen Boots (WBA)?
What is the market cap of Walgreen Boots (WBA)?
